165 related articles for article (PubMed ID: 17976707)
21. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
[TBL] [Abstract][Full Text] [Related]
22. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
23. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.
Huh WK; Gomez-Navarro J; Arafat WO; Xiang J; Mahasreshti PJ; Alvarez RD; Barnes MN; Curiel DT
Gynecol Oncol; 2001 Nov; 83(2):370-7. PubMed ID: 11606099
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.
Wang Z; Cai L; Wang H
Gynecol Oncol; 2005 Mar; 96(3):643-50. PubMed ID: 15721406
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.
Baker AH; George SJ; Zaltsman AB; Murphy G; Newby AC
Br J Cancer; 1999 Mar; 79(9-10):1347-55. PubMed ID: 10188875
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
[TBL] [Abstract][Full Text] [Related]
27. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
28. [The feasibility and mechanism of recombinant adenovirus Ad - p 14 ARF in gene therapy of liver cancer].
Song HF; Qian HL; Zhang XY; Liang X; Fu M; Lin C
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):641-5. PubMed ID: 17274365
[TBL] [Abstract][Full Text] [Related]
29. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
[TBL] [Abstract][Full Text] [Related]
30. [Construction of adenovirus vector expressing TIP30 and its tumor suppressive effect in vitro and in vivo].
Zhang X; Zhao J; Li XD; Yuan CT; Wang HQ; Wu MC; Xiao H; Guo YJ
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):85-8. PubMed ID: 15059324
[TBL] [Abstract][Full Text] [Related]
31. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.
Ahonen M; Baker AH; Kähäri VM
Cancer Res; 1998 Jun; 58(11):2310-5. PubMed ID: 9622064
[TBL] [Abstract][Full Text] [Related]
33. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
34. [Experimental studies on inhibition of malignant melanoma growth by gene transfer of adenovirus-mediated averse vascular endothelial growth factor165].
Cui Z; Cen Y; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 May; 20(5):499-503. PubMed ID: 16752833
[TBL] [Abstract][Full Text] [Related]
35. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antitumor effects of in vivo production of human endostatin and tissue inhibitor of metalloproteinase-1 in mice after subcutaneous implantation of primary fibroblasts transfected by adenovirus-mediated gene delivery.
Shen WG; Zhu J; Zhang Y; Su Q
Chin Med J (Engl); 2010 Apr; 123(7):922-8. PubMed ID: 20497689
[TBL] [Abstract][Full Text] [Related]
37. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
38. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
39. Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy.
Hsu KF; Wu CL; Huang SC; Hsieh JL; Huang YS; Chen YF; Shen MR; Chung WJ; Chou CY; Shiau AL
Cancer Gene Ther; 2008 Aug; 15(8):526-34. PubMed ID: 18497852
[TBL] [Abstract][Full Text] [Related]
40. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo.
Rigg AS; Lemoine NR
Cancer Gene Ther; 2001 Nov; 8(11):869-78. PubMed ID: 11773977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
